We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$89.7B
AUM Growth
-$6.37B
Cap. Flow
-$1.25B
Cap. Flow %
-1.39%
Top 10 Hldgs %
19.07%
Holding
4,574
New
72
Increased
2,420
Reduced
1,279
Closed
355

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 16.22%
3 Financials 13.45%
4 Consumer Discretionary 9.63%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VINC
4226
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
0
GATO
4227
DELISTED
Gatos Silver, Inc.
GATO
-25
Closed
PSTX
4228
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-15
Closed
AUMN
4229
DELISTED
Golden Minerals Company
AUMN
$0 ﹤0.01%
+24
New +$175
TWKS
4230
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
-245
Closed -$3K
JWSM
4231
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
-416,910
Closed -$4.1M
ITI
4232
DELISTED
Iteris, Inc.
ITI
-23
Closed
LLAP
4233
DELISTED
Terran Orbital Corporation
LLAP
$0 ﹤0.01%
131
+16
+14% +$65
GRTS
4234
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-23
Closed
ORAN
4235
DELISTED
Orange
ORAN
-1,428
Closed -$17K
IXAQW
4236
DELISTED
IX Acquisition Corp. Warrant
IXAQW
$0 ﹤0.01%
61
TBIO
4237
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
0
GTHX
4238
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-1
Closed
DNA.WS
4239
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$0 ﹤0.01%
220
TLIS
4240
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
-1
Closed
ASXC
4241
DELISTED
Asensus Surgical, Inc.
ASXC
$0 ﹤0.01%
1
MOR
4242
DELISTED
MorphoSys AG American Depositary Shares
MOR
-2,765
Closed -$13K
AINC
4243
DELISTED
Ashford Inc.
AINC
$0 ﹤0.01%
1
NFYS
4244
DELISTED
Enphys Acquisition Corp.
NFYS
-210,000
Closed -$2.02M
SHPWW
4245
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$0 ﹤0.01%
4,730
NEXI
4246
DELISTED
NexImmune, Inc. Common Stock
NEXI
0
OSG
4247
DELISTED
Overseas Shipholding Group Inc.
OSG
-5,274
Closed -$11K
BLUA.WS
4248
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$0 ﹤0.01%
2,786
CSSE
4249
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$0 ﹤0.01%
2
-3
-60% -$28
UGIC
4250
DELISTED
UGI Corporation
UGIC
-11,002
Closed -$1M

Similar funds

Credit Suisse's Q3 2022 Portfolio in Review

As of Q3 2022, Credit Suisse held 4,574 positions worth $89.7B, down 6.6% from $96.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse's Q3 2022 filing shows 72 new, 2,420 increased, 1,279 reduced and 355 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $205M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2022 buy was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M.
  • Credit Suisse added most to Apple in Q3 2022, an estimated $180M increase.
  • Credit Suisse's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $205M.
  • Credit Suisse fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $40.9M.
  • Credit Suisse's ten largest holdings make up 19% of its $89.7B portfolio in Q3 2022.
  • Credit Suisse opened 72 new positions and closed 355 in Q3 2022.
  • Credit Suisse's portfolio value fell 6.6% quarter-over-quarter to $89.7B.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.